EGFR and cancer: Therefore, locally elevated estrogen formation affects the development and progression of cancer tissues and cells (HCC, HepG2) by activating the rapid signalling pathway mediated via amphiregulin (AREG; a member of the EGF family), a ligand of EGF-R (epidermal growth factor receptor) [138,140].